PATENT CLAIM ANALYSIS

Application Number: 15877133
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["705", "002000"]

Abstract:
Systems and methods are provided for over the counter statin delivery to a subject. Survey results from the subject are run against a first plurality of filters. When a filter in the first plurality of filters is fired, the subject is deemed not qualified. The survey results are also run against a second plurality of filters. When a respective filter in the second plurality is fired, the subject is provided with a corresponding warning. The method proceeds to a fulfillment process when no filter in the first plurality fires and the subject has acknowledged each warning associated with each fired filter in the second plurality. The fulfillment stores the composition order, communicates a drug facts label for the statin to the subject, and authorizes, upon subject confirmation that the label has been read, provision of the statin to the subject, the authorization including a destination associated with the subject.

Claim (Index 1):
A method for qualifying a human for delivery of a statin pharmaceutical composition over the counter to lower cholesterol, the method comprising:\n a) obtaining a first information set from the human comprising:\n a sex of the human, \n whether the human is female and one of (i) pregnant, (ii) breastfeeding, or (iii) planning to become pregnant, \n whether the human has or has ever had a liver condition, \n an age of the human, \n a total cholesterol level of the human, \n a HDL cholesterol count of the human, \n a systolic blood pressure of the human, \n a race of the human, \n whether the human is on a high blood pressure treatment, \n whether the human is taking one or more compositions that interact with the statin pharmaceutical composition, wherein the one or more compositions include cyclosporine, \n a smoking status of the human, \n a diabetes status of the human, \n an alcohol consumption status of the human, \n whether the human has had an adverse reaction to a cholesterol lowering composition, and \n whether the human has ever had an atherosclerotic cardiovascular event or had a heart procedure; \n b) running all or a portion of the information set against a first plurality of filters of a first category class, wherein, when a respective filter in the first plurality of filters is fired, the human is deemed not qualified for delivery of the statin pharmaceutical composition and the method is terminated without delivery of the statin pharmaceutical composition to the human, wherein the first plurality of filters comprises:\n a pregnancy filter, \n a cyclosporine filter, and \n a liver condition or allergic reaction to the statin pharmaceutical composition filter, \n c) running all or a portion of the first information set against a second plurality of filters of a second category class, wherein, when a respective filter in the second plurality of filters is fired, the human is provided with a warning corresponding to the respective filter, and wherein the second plurality of filters comprises:\n a total cholesterol level filter, \n a pooled cohort equation filter that incorporates the sex of the human, the race of the human, the age of the human, the total cholesterol level of the human, the high-density lipoprotein cholesterol count of the human, the systolic blood pressure of the human, whether the human is taking a composition that interacts with a statin, the smoking status of the human, and the diabetes status of the human to derive a likelihood for a atherosclerotic cardiovascular condition, wherein when the likelihood satisfies a first threshold range or a first threshold value the pooled cohort equation filter is deemed fired, \n an age filter, \n a drug interaction filter, \n an alcohol consumption filter, \n an adverse reaction filter, and an atherosclerotic cardiovascular event filter;\n d) obtaining acknowledgment from the human for the warning issued to the human by any filter in the second plurality of filters; and \n e) proceeding with a fulfillment process when (i) no filter in the first plurality of filters has been fired and (ii) the human has acknowledged each warning associated with each filter in the second plurality of filters that was fired, wherein the fulfillment process comprises:\n storing an indication in a human profile of an initial order for the statin pharmaceutical composition, \n communicating an over the counter drug label for the statin pharmaceutical composition to the human, and \n authorizing, upon confirmation from the human that the over the counter drug label has been received and read, provision of the statin pharmaceutical composition to the human, wherein the authorization includes a destination associated with the human.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 86.0
- Lexical Diversity: 2.36232
- Patent Class: 705.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15385747', '14370722', '15572330', '12690797', '12394819']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.1036550296086137
- 35 USC 102 Novelty (BERT): 0.5619897246592832
- Combined Prediction Score: 0.1494884991136806
- Mean Citation Score: 245.05178600000005
- Max Citation Score: 496.88074000000006
- Similarity Product: 329.47220276379346

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test